Here are the 424B prospectus supplements from Raytech Holding Limited (RAY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow RAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RAY filings page.
Raytech Holding Limited offers 3,149,832 Ordinary Shares at US$1.97 per share in a primary placement under a prospectus supplement. The offering prices total gross proceeds of US$6,217,768 and net proceeds are estimated at US$6,084,660. The prospectus states total Ordinary Shares outstanding before this offering as 2,724,911 and immediately after this offering as 5,874,743. Two purchasers—Fortune Genesis Holdings Limited and WK Frater Holdings Limited—are affiliated with certain directors and large shareholders and will each purchase 999,014 Ordinary Shares at the public offering price; the company relies on the foreign private issuer home country practice exemption instead of Nasdaq shareholder approval. Net proceeds are earmarked for general corporate and working capital purposes, expansion into personal health care electronics and integration/post-closing costs related to the Worry free Group acquisition.